SENS · Senseonics Holdings, Inc.

Senseonics Holdings, Inc., a commercial-stage medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. Its products include Eversense, Eversense XL, Eversense E3, and Eversense 365, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and an app for real-time diabetes monitoring and management. The company serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.

Cap structure and valuation

Cap structure
SP	$5.50
SO	41.8M
Options	1.5M
Warrants	2.4M
FD SO	45.7M
MC	$251.2M

Cash	$29.6M
Total debt	$35.9M
EV	$257.5M

TTM Multiples
EV / Revenue	6.3x
EV / EBITDA	—
MC / Net Income	—
EV / FCF	—
MC / FCF	—

MC = SP × FD SO. EV = MC + Debt − Cash. SP = previous yfinance close. Balance-sheet figures as of 2026-05-04. Multiples use TTM (sum of last 4 quarters); shown as "—" when the denominator is zero or negative.

Financial statements

	3/31/26	12/31/25	9/30/25	6/30/25
Total Revenue	11.71	14.26	8.10	6.65
Revenue YoY %	87.2%	71.8%	89.9%	36.7%
Cost of Revenue	4.77	6.59	4.63	3.53
Gross Profit	6.94	7.67	3.47	3.12
Gross Profit YoY %	361.1%	94.1%	185.6%	947.3%
Gross Margin %	59.3%	53.8%	42.8%	46.9%

SG&A	30.18	19.77	15.31	9.73
R&D	8.61	8.82	7.76	7.71
Operating Expense	38.79	28.59	23.07	17.44

Operating Income	(31.85)	(20.93)	(19.60)	(14.32)
Operating Income YoY %	(136.1%)	(46.6%)	14.2%	26.5%
Operating Margin %	(271.9%)	(146.8%)	(242.1%)	(215.4%)
EBITDA	(31.30)	(20.54)	(19.23)	(13.95)
EBITDA Margin %	(267.3%)	(144.1%)	(237.5%)	(209.9%)

Interest Expense	1.19	1.21	1.17	1.15
Pretax Income	(32.33)	(20.82)	(19.53)	(14.50)
Tax Provision	0.00	0.00	0.00	0.00
Net Income	(32.33)	(20.82)	(19.53)	(14.50)
Net Margin %	(276.1%)	(146.1%)	(241.3%)	(218.1%)

Diluted EPS	-$0.71	-$0.47	-$0.43	-$0.02
Basic EPS	-$0.71	-$0.47	-$0.43	-$0.02
Diluted Avg Shares	45.8	1.2	45.0	813.4
Basic Avg Shares	45.8	1.2	45.0	813.4

	LTM	12/31/25	12/31/24	12/31/23	12/31/22
Total Revenue	40.71	35.26	22.47	22.39	16.39
Revenue YoY %	15.5%	56.9%	0.4%	36.6%	—
Cost of Revenue	19.51	19.49	21.94	19.30	13.66
Gross Profit	21.20	15.76	0.53	3.09	2.73
Gross Profit YoY %	34.5%	2857.4%	(82.8%)	13.4%	—
Gross Margin %	52.1%	44.7%	2.4%	13.8%	16.6%

SG&A	74.99	52.51	34.23	29.94	31.63
R&D	32.90	31.59	41.14	48.75	39.72
Operating Expense	107.89	84.10	75.38	78.69	71.35

Operating Income	(86.69)	(68.34)	(74.84)	(75.60)	(68.63)
Operating Income YoY %	(26.9%)	8.7%	1.0%	(10.2%)	—
Operating Margin %	(213.0%)	(193.8%)	(333.0%)	(337.7%)	(418.7%)
EBITDA	(85.02)	(66.83)	(73.37)	(74.33)	(67.64)
EBITDA Margin %	(208.8%)	(189.5%)	(326.5%)	(332.0%)	(412.7%)

Interest Expense	4.71	4.95	8.44	11.11	18.70
Pretax Income	(87.19)	(69.11)	(78.62)	(60.39)	142.12
Tax Provision	0.00	0.00	0.00	0.00	0.00
Net Income	(87.19)	(69.11)	(78.62)	(60.39)	142.12
Net Income to Common	(87.19)	(69.10)	(78.60)	(60.40)	142.10
Net Margin %	(214.2%)	(196.0%)	(349.8%)	(269.7%)	867.2%

Diluted EPS	-$1.63	-$1.66	-$0.12	-$0.11	-$0.11
Basic EPS	-$1.63	-$1.66	-$0.12	-$0.11	$0.30
Diluted Avg Shares	45.8	41.7	629.7	568.0	618.2
Basic Avg Shares	45.8	41.7	629.7	568.0	468.0

	3/31/26	12/31/25	9/30/25	6/30/25
Cash & Equivalents	29.61	40.23	34.46	31.52
Receivables	14.71	12.12	7.20	5.16
Inventory	8.31	6.70	6.32	4.71
Total Current Assets	92.28	117.53	131.28	141.59

Total Assets	102.86	126.27	139.92	150.27

Accounts Payable	3.19	4.06	5.93	2.27
Total Current Liabilities	26.32	24.35	21.07	14.78
Long-term Debt	35.91	35.59	35.27	35.23
Total Liabilities	68.52	65.22	61.76	55.55

Retained Earnings	(1,049.32)	(1,016.99)	(996.16)	(976.63)
Total Equity	34.34	61.05	78.17	94.72

	LTM	12/31/25	12/31/24	12/31/23	12/31/22
Cash & Equivalents	29.61	40.23	74.60	75.71	35.79
Receivables	14.71	12.12	6.29	—	—
Inventory	8.31	6.70	4.42	8.78	7.31
Total Current Assets	92.28	117.53	91.44	130.03	161.20

Net PPE	—	—	—	1.18	1.11
Total Assets	102.86	126.27	100.44	138.22	177.67

Accounts Payable	3.19	4.06	3.21	4.57	0.42
Total Current Liabilities	26.32	24.35	38.85	17.26	31.47
Long-term Debt	35.91	35.59	34.70	41.20	56.38
Total Liabilities	68.52	65.22	79.34	64.77	142.59
Mezzanine Equity	—	—	37.66	37.66	37.66

Retained Earnings	(1,049.32)	(1,016.99)	(947.87)	(869.26)	(808.87)
Total Equity	34.34	61.05	(16.55)	35.80	(2.58)

	3/31/26	12/31/25	9/30/25	6/30/25
Net Income	(32.33)	(20.82)	(19.53)	(14.50)
D&A	0.55	0.38	0.38	0.37
Stock-Based Comp	2.28	2.62	2.79	2.89
Operating Cash Flow	(32.02)	(17.96)	(15.82)	(9.27)

CapEx	(0.11)	(0.39)	(0.16)	(0.12)
Investing Cash Flow	18.00	22.64	18.89	(69.63)

Stock Issuance	3.49	—	—	—
Financing Cash Flow	3.41	1.10	(0.13)	71.11

Free Cash Flow	(32.14)	(18.36)	(15.98)	(9.39)

	LTM	12/31/25	12/31/24	12/31/23	12/31/22
Net Income	(87.19)	(69.10)	(78.60)	(60.40)	142.10
D&A	1.67	1.51	1.48	1.28	0.98
Stock-Based Comp	10.59	10.15	9.22	8.67	8.62
Operating Cash Flow	(75.07)	(59.13)	(60.47)	(70.16)	(66.31)

CapEx	(0.79)	(1.12)	(2.24)	(0.35)	(0.31)
Investing Cash Flow	(10.10)	(53.42)	32.84	89.71	26.88

Financing Cash Flow	75.48	78.19	26.83	20.37	41.76

Free Cash Flow	(75.87)	(60.24)	(62.70)	(70.51)	(66.62)

	3/31/26	12/31/25	9/30/25	6/30/25
Current Ratio	3.51	4.83	6.23	9.58
Quick Ratio	3.19	4.55	5.93	9.26
Debt / Equity	2.00	1.07	0.79	0.59
EBITDA Margin %	(267.3%)	(144.1%)	(237.5%)	(209.9%)
Working Capital	65.96	93.19	110.20	126.81
Net Debt	6.30	(4.65)	0.81	3.71
ROE %	(94.2%)	(34.1%)	(25.0%)	(15.3%)
ROA %	(31.4%)	(16.5%)	(14.0%)	(9.6%)

	LTM	12/31/25	12/31/24	12/31/23	12/31/22
Current Ratio	3.51	4.83	2.35	7.53	5.12
Quick Ratio	3.19	4.55	2.24	7.03	4.89
Debt / Equity	2.00	1.07	-4.79	1.81	-55.35
EBITDA Margin %	(208.8%)	(189.5%)	(326.5%)	(332.0%)	(412.7%)
Working Capital	65.96	93.19	52.59	112.77	129.73
Net Debt	6.30	(4.65)	(39.89)	(34.51)	20.59
ROE %	(253.9%)	(113.2%)	474.9%	(168.7%)	(5517.0%)
ROA %	(84.8%)	(54.7%)	(78.3%)	(43.7%)	80.0%

Insider activity (last 2 years)

Date Filed	Reporter	Relationship	Trans. Date	Code	Shares	Price	Total Value
2026-05-13	ROEDER DOUGLAS A	Director	2026-05-12	P	22,686	$5.56	$126,134
2026-04-02	ROEDER DOUGLAS A	Director	2026-04-01	A	2,218	$6.65	$14,750
2026-04-02	Prince Douglas S	Director	2026-04-01	A	1,221	$6.65	$8,120
2026-04-02	Fiorentino Edward	Director	2026-04-01	A	2,124	$6.65	$14,125
2026-04-02	Steven Edelman	Director	2026-04-01	A	1,936	$6.65	$12,874
2026-03-16	ROEDER DOUGLAS A	Director	2026-03-13	P	17,500	$5.73	$100,275
2026-03-16	Goodnow Timothy T	Director, Officer (President and CEO)	2026-03-13	P	17,225	$5.79	$99,733
2026-01-05	Prince Douglas S	Director	2026-01-02	A	1,379	$5.89	$8,122
2026-01-05	ROEDER DOUGLAS A	Director	2026-01-02	A	2,504	$5.89	$14,749
2026-01-05	Fiorentino Edward	Director	2026-01-02	A	2,398	$5.89	$14,124
2026-01-05	Steven Edelman	Director	2026-01-02	A	2,185	$5.89	$12,870
2025-11-18	Sullivan Frederick T.	Officer (Chief Financial Officer)	2025-11-15	F	(6,402)	$6.26	-$40,077
2025-11-18	Kaufman Francine	Director, Officer (Chief Medical Officer)	2025-11-15	F	(4,605)	$6.26	-$28,827
2025-11-18	JAIN Mukul	Officer (Chief Operating Officer)	2025-11-15	F	(10,317)	$6.26	-$64,584
2025-11-18	Horton Kenneth L	Officer (GC & Corp. Development Advisor)	2025-11-15	F	(5,997)	$6.26	-$37,541
2025-11-18	Goodnow Timothy T	Director, Officer (President and CEO)	2025-11-15	F	(27,067)	$6.26	-$169,439
2025-11-13	Steven Edelman	Director	2025-11-10	P	10,000	$6.55	$65,500
2025-11-10	ROEDER DOUGLAS A	Director	2025-11-07	P	15,000	$5.83	$87,450
2025-11-10	Sullivan Frederick T.	Officer (Chief Financial Officer)	2025-11-07	P	5,415	$5.88	$31,840
2025-11-10	Goodnow Timothy T	Director, Officer (President and CEO)	2025-11-07	P	(17,210)	$5.87	-$101,023
2025-10-03	Prince Douglas S	Director	2025-10-01	A	19,673	$0.41	$8,125
2025-10-03	ROEDER DOUGLAS A	Director	2025-10-01	A	35,714	$0.41	$14,750
2025-10-03	Fiorentino Edward	Director	2025-10-01	A	34,200	$0.41	$14,125
2025-10-03	Steven Edelman	Director	2025-10-01	A	31,174	$0.41	$12,875
2025-07-03	Prince Douglas S	Director	2025-07-01	A	17,069	$0.48	$8,125
2025-07-03	ROEDER DOUGLAS A	Director	2025-07-01	A	30,987	$0.48	$14,750
2025-07-03	Fiorentino Edward	Director	2025-07-01	A	29,674	$0.48	$14,125
2025-07-03	Steven Edelman	Director	2025-07-01	A	27,048	$0.48	$12,875
2025-06-17	Sullivan Frederick T.	Officer (Chief Financial Officer)	2025-06-16	F	(27,263)	$0.51	-$13,904
2025-06-17	Kaufman Francine	Director, Officer (Chief Medical Officer)	2025-06-16	F	(28,853)	$0.51	-$14,715
2025-06-17	JAIN Mukul	Officer (Chief Operating Officer)	2025-06-16	F	(58,761)	$0.51	-$29,968
2025-06-17	Horton Kenneth L	Officer (GC & Corp. Development Advisor)	2025-06-16	F	(35,784)	$0.51	-$18,250
2025-06-17	Goodnow Timothy T	Director, Officer (President and CEO)	2025-06-16	F	(79,646)	$0.51	-$40,619
2025-05-29	HANSEN BRIAN B	Director	2025-05-23	A	842,084	—	$0
2025-05-29	HANSEN BRIAN B	Director	2025-05-23	A	1,187,987	—	$0
2025-05-28	Prince Douglas S	Director	2025-05-23	A	111,386	—	$0
2025-05-28	Prince Douglas S	Director	2025-05-23	A	157,234	—	$0
2025-05-28	Larkin Sharon	Director	2025-05-23	A	111,386	—	$0
2025-05-28	Larkin Sharon	Director	2025-05-23	A	157,234	—	$0
2025-05-28	Steven Edelman	Director	2025-05-23	A	111,386	—	$0
2025-05-28	Steven Edelman	Director	2025-05-23	A	157,234	—	$0
2025-05-28	DeFalco Stephen P	Director	2025-05-23	A	111,386	—	$0
2025-05-28	DeFalco Stephen P	Director	2025-05-23	A	157,234	—	$0
2025-05-28	Kaufman Francine	Director, Officer (Chief Medical Officer)	2025-05-23	A	455,716	—	$0
2025-05-28	Kaufman Francine	Director, Officer (Chief Medical Officer)	2025-05-23	A	642,911	—	$0
2025-05-28	Horton Kenneth L	Officer (GC & Corp. Development Advisor)	2025-05-23	A	505,251	—	$0
2025-05-28	Horton Kenneth L	Officer (GC & Corp. Development Advisor)	2025-05-23	A	712,792	—	$0
2025-05-28	Fiorentino Edward	Director	2025-05-23	A	111,386	—	$0
2025-05-28	Fiorentino Edward	Director	2025-05-23	A	157,234	—	$0
2025-05-28	ROEDER DOUGLAS A	Director	2025-05-23	A	111,386	—	$0
2025-05-28	ROEDER DOUGLAS A	Director	2025-05-23	A	157,234	—	$0
2025-05-28	JAIN Mukul	Officer (Chief Operating Officer)	2025-05-23	A	990,688	—	$0
2025-05-28	JAIN Mukul	Officer (Chief Operating Officer)	2025-05-23	A	1,397,632	—	$0
2025-05-28	Sullivan Frederick T.	Officer (Chief Financial Officer)	2025-05-23	A	693,481	—	$0
2025-05-28	Sullivan Frederick T.	Officer (Chief Financial Officer)	2025-05-23	A	978,342	—	$0
2025-05-28	Goodnow Timothy T	Director, Officer (President and CEO)	2025-05-23	A	2,025,956	—	$0
2025-05-28	Goodnow Timothy T	Director, Officer (President and CEO)	2025-05-23	A	2,858,157	—	$0
2025-05-19	Sullivan Frederick T.	Officer (Chief Financial Officer)	2025-05-15	F	(112,811)	$0.55	-$62,046
2025-05-19	Kaufman Francine	Director, Officer (Chief Medical Officer)	2025-05-15	F	(101,587)	$0.55	-$55,873
2025-05-19	JAIN Mukul	Officer (Chief Operating Officer)	2025-05-15	F	(260,393)	$0.55	-$143,216
2025-05-19	Horton Kenneth L	Officer (GC & Corp. Development Advisor)	2025-05-15	F	(167,085)	$0.55	-$91,897
2025-05-19	Goodnow Timothy T	Director, Officer (President and CEO)	2025-05-15	F	(379,164)	$0.55	-$208,540
2025-04-03	Fiorentino Edward	Director	2025-04-01	A	21,243	$0.66	$14,124
2025-04-03	Prince Douglas S	Director	2025-04-01	A	12,219	$0.66	$8,124
2025-04-03	Steven Edelman	Director	2025-04-01	A	19,363	$0.66	$12,874
2025-04-03	ROEDER DOUGLAS A	Director	2025-04-01	A	22,183	$0.66	$14,749
2025-01-03	ROEDER DOUGLAS A	Director	2025-01-02	A	31,183	$0.47	$14,750
2025-01-03	Fiorentino Edward	Director	2025-01-02	A	29,862	$0.47	$14,125
2025-01-03	Prince Douglas S	Director	2025-01-02	A	17,177	$0.47	$8,125
2025-01-03	Steven Edelman	Director	2025-01-02	A	27,219	$0.47	$12,875
2024-12-20	ROEDER DOUGLAS A	Director	2024-12-13	P	75,000	$0.50	$37,500
2024-12-16	ROEDER DOUGLAS A	Director	2024-12-13	P	25,000	$0.50	$12,500
2024-12-16	ROEDER DOUGLAS A	Director	2024-12-12	P	300,000	$0.41	$123,000
2024-12-12	Sullivan Frederick T.	Officer (Chief Financial Officer)	2024-12-12	P	124,933	$0.38	$47,475
2024-12-10	Goodnow Timothy T	Director, Officer (President and CEO)	2024-12-10	P	315,000	$0.31	$97,650
2024-11-18	Sullivan Frederick T.	Officer (Chief Financial Officer)	2024-11-15	F	(181,627)	$0.28	-$50,856
2024-11-18	Kaufman Francine	Director, Officer (Chief Medical Officer)	2024-11-15	F	(118,645)	$0.28	-$33,221
2024-11-18	JAIN Mukul	Officer (Chief Operating Officer)	2024-11-15	F	(282,546)	$0.28	-$79,113
2024-11-18	Horton Kenneth L	Officer (GC & Corp. Development Advisor)	2024-11-15	F	(187,665)	$0.28	-$52,546
2024-11-18	Goodnow Timothy T	Director, Officer (President and CEO)	2024-11-15	F	(632,166)	$0.28	-$177,006
2024-10-02	Steven Edelman	Director	2024-10-01	A	38,193	$0.34	$12,875
2024-10-02	Fiorentino Edward	Director	2024-10-01	A	41,901	$0.34	$14,125
2024-10-02	ROEDER DOUGLAS A	Director	2024-10-01	A	43,755	$0.34	$14,750
2024-10-02	Prince Douglas S	Director	2024-10-01	A	24,102	$0.34	$8,125
2024-07-03	Prince Douglas S	Director	2024-07-01	A	20,528	$0.40	$8,125
2024-07-03	Fiorentino Edward	Director	2024-07-01	A	35,687	$0.40	$14,125
2024-07-03	Steven Edelman	Director	2024-07-01	A	32,529	$0.40	$12,875
2024-06-18	Kaufman Francine	Director, Officer (Chief Medical Officer)	2024-06-15	F	(64,722)	$0.39	-$25,242
2024-06-18	JAIN Mukul	Officer (Chief Operating Officer)	2024-06-15	F	(132,448)	$0.39	-$51,655
2024-06-18	Horton Kenneth L	Officer (GC & Corp. Development Advisor)	2024-06-15	F	(80,785)	$0.39	-$31,506
2024-06-18	Sullivan Frederick T.	Officer (Chief Financial Officer)	2024-06-15	F	(79,242)	$0.39	-$30,904
2024-06-18	Goodnow Timothy T	Director, Officer (President and CEO)	2024-06-15	F	(275,206)	$0.39	-$107,330
2024-05-24	Kaufman Francine	Director, Officer (Chief Medical Officer)	2024-05-23	A	1,024,270	—	$0
2024-05-24	Horton Kenneth L	Officer (GC & Corp. Development Advisor)	2024-05-23	A	1,135,604	—	$0
2024-05-24	JAIN Mukul	Officer (Chief Operating Officer)	2024-05-23	A	2,204,408	—	$0
2024-05-24	Sullivan Frederick T.	Officer (Chief Financial Officer)	2024-05-23	A	1,336,005	—	$0
2024-05-24	Goodnow Timothy T	Director, Officer (President and CEO)	2024-05-23	A	4,553,551	—	$0
2024-05-24	ROEDER DOUGLAS A	Director	2024-05-22	A	236,344	—	$0
2024-05-24	Steven Edelman	Director	2024-05-22	A	236,344	—	$0
2024-05-24	Raab Anthony R.	Director	2024-05-22	A	236,344	—	$0
2024-05-24	Prince Douglas S	Director	2024-05-22	A	236,344	—	$0
2024-05-24	Larkin Sharon	Director	2024-05-22	A	236,344	—	$0
2024-05-24	DeFalco Stephen P	Director	2024-05-22	A	236,344	—	$0
2024-05-24	Fiorentino Edward	Director	2024-05-22	A	236,344	—	$0
2024-05-17	Sullivan Frederick T.	Officer (Chief Financial Officer)	2024-05-15	F	(102,386)	$0.50	-$51,193
2024-05-17	Goodnow Timothy T	Director, Officer (President and CEO)	2024-05-15	F	(359,114)	$0.50	-$179,557
2024-05-17	Kaufman Francine	Director, Officer (Chief Medical Officer)	2024-05-15	F	(53,923)	$0.50	-$26,962
2024-05-17	JAIN Mukul	Officer (Chief Operating Officer)	2024-05-15	F	(151,796)	$0.50	-$75,898
2024-05-17	Horton Kenneth L	Officer (GC & Corp. Development Advisor)	2024-05-15	F	(108,100)	$0.50	-$54,050